Search

Alexander J. Yi

Examiner (ID: 13085, Phone: (571)270-7696 , Office: P/2641 )

Most Active Art Unit
2643
Art Unit(s)
2641, 2617, 2643
Total Applications
522
Issued Applications
341
Pending Applications
40
Abandoned Applications
151

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4960045 [patent_doc_number] => 20080274470 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER' [patent_app_type] => utility [patent_app_number] => 12/114584 [patent_app_country] => US [patent_app_date] => 2008-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3897 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20080274470.pdf [firstpage_image] =>[orig_patent_app_number] => 12114584 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/114584
NON-INVASIVE DETECTION OF ENDOMETRIAL CANCER May 1, 2008 Abandoned
Array ( [id] => 5289925 [patent_doc_number] => 20090022655 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-22 [patent_title] => 'Nanotubes for Cancer Therapy and Diagnostics' [patent_app_type] => utility [patent_app_number] => 12/112986 [patent_app_country] => US [patent_app_date] => 2008-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10810 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20090022655.pdf [firstpage_image] =>[orig_patent_app_number] => 12112986 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/112986
Nanotubes for cancer therapy and diagnostics Apr 29, 2008 Issued
Array ( [id] => 4739476 [patent_doc_number] => 20080233129 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Ligand that has binding specificity for IL-4 and/or lL-13' [patent_app_type] => utility [patent_app_number] => 12/150487 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 50160 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233129.pdf [firstpage_image] =>[orig_patent_app_number] => 12150487 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/150487
Ligand that has binding specificity for IL-4 and/or lL-13 Apr 28, 2008 Abandoned
Array ( [id] => 4739477 [patent_doc_number] => 20080233130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'Ligand that has binding specificity for IL-4 and/or IL-13' [patent_app_type] => utility [patent_app_number] => 12/150567 [patent_app_country] => US [patent_app_date] => 2008-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 50095 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233130.pdf [firstpage_image] =>[orig_patent_app_number] => 12150567 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/150567
Ligand that has binding specificity for IL-4 and/or IL-13 Apr 28, 2008 Abandoned
Array ( [id] => 5322874 [patent_doc_number] => 20090060864 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-03-05 [patent_title] => 'Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies' [patent_app_type] => utility [patent_app_number] => 12/148629 [patent_app_country] => US [patent_app_date] => 2008-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13764 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20090060864.pdf [firstpage_image] =>[orig_patent_app_number] => 12148629 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/148629
Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies Apr 20, 2008 Issued
Array ( [id] => 5458226 [patent_doc_number] => 20090258378 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-10-15 [patent_title] => 'STRESS-INDUCED PHOSPHOPROTEIN 1 AS A BIOMARKER FOR THE DETECTION OF HUMAN OVARIAN CANCERS AND ENDOMETRIOSIS' [patent_app_type] => utility [patent_app_number] => 12/102807 [patent_app_country] => US [patent_app_date] => 2008-04-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 8355 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0258/20090258378.pdf [firstpage_image] =>[orig_patent_app_number] => 12102807 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/102807
Stress-induced phosphoprotein 1 as a biomarker for the detection of human ovarian cancers and endometriosis Apr 13, 2008 Issued
Array ( [id] => 177700 [patent_doc_number] => 07655408 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'PCA3 messenger RNA species in benign and malignant prostate tissues' [patent_app_type] => utility [patent_app_number] => 12/098577 [patent_app_country] => US [patent_app_date] => 2008-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 13313 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 253 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655408.pdf [firstpage_image] =>[orig_patent_app_number] => 12098577 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/098577
PCA3 messenger RNA species in benign and malignant prostate tissues Apr 6, 2008 Issued
Array ( [id] => 4683161 [patent_doc_number] => 20080249387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'Enhanced monitor compliance' [patent_app_type] => utility [patent_app_number] => 12/080318 [patent_app_country] => US [patent_app_date] => 2008-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4097 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0249/20080249387.pdf [firstpage_image] =>[orig_patent_app_number] => 12080318 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/080318
Enhanced monitor compliance Apr 1, 2008 Abandoned
Array ( [id] => 4561088 [patent_doc_number] => 07846447 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-12-07 [patent_title] => 'Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction' [patent_app_type] => utility [patent_app_number] => 12/077508 [patent_app_country] => US [patent_app_date] => 2008-03-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7461 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 68 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/846/07846447.pdf [firstpage_image] =>[orig_patent_app_number] => 12077508 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/077508
Immunotherapy of epithelial tumors using intralesional injection of antigens that induce a delayed type hypersensitivity reaction Mar 18, 2008 Issued
Array ( [id] => 4727235 [patent_doc_number] => 20080206777 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors' [patent_app_type] => utility [patent_app_number] => 12/072651 [patent_app_country] => US [patent_app_date] => 2008-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11130 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206777.pdf [firstpage_image] =>[orig_patent_app_number] => 12072651 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/072651
Gene and protein expression profiles associated with the therapeutic efficacy of EGFR-TK inhibitors Feb 26, 2008 Abandoned
Array ( [id] => 4718542 [patent_doc_number] => 20080241064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN' [patent_app_type] => utility [patent_app_number] => 12/036875 [patent_app_country] => US [patent_app_date] => 2008-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 26583 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20080241064.pdf [firstpage_image] =>[orig_patent_app_number] => 12036875 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036875
COMPOSITIONS AND METHODS FOR IDENTIFYING AND TARGETING CANCER CELLS OF ALIMENTARY CANAL ORIGIN Feb 24, 2008 Abandoned
Array ( [id] => 4676152 [patent_doc_number] => 20080213782 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-04 [patent_title] => 'SOCS-1 Gene Methylation in Cancer' [patent_app_type] => utility [patent_app_number] => 12/036182 [patent_app_country] => US [patent_app_date] => 2008-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29224 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20080213782.pdf [firstpage_image] =>[orig_patent_app_number] => 12036182 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/036182
SOCS-1 gene methylation in cancer Feb 21, 2008 Issued
Array ( [id] => 196334 [patent_doc_number] => 07635759 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Gene encoding labyrinthin, a marker for cancer' [patent_app_type] => utility [patent_app_number] => 12/029113 [patent_app_country] => US [patent_app_date] => 2008-02-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8291 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635759.pdf [firstpage_image] =>[orig_patent_app_number] => 12029113 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/029113
Gene encoding labyrinthin, a marker for cancer Feb 10, 2008 Issued
Array ( [id] => 132307 [patent_doc_number] => 07695915 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/012530 [patent_app_country] => US [patent_app_date] => 2008-01-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 27980 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 90 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/695/07695915.pdf [firstpage_image] =>[orig_patent_app_number] => 12012530 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/012530
Molecular prognostic signature for predicting breast cancer distant metastasis, and uses thereof Jan 30, 2008 Issued
Array ( [id] => 6374570 [patent_doc_number] => 20100081153 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES' [patent_app_type] => utility [patent_app_number] => 12/018110 [patent_app_country] => US [patent_app_date] => 2008-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 24062 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20100081153.pdf [firstpage_image] =>[orig_patent_app_number] => 12018110 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/018110
CANCER ASSOCIATED PROTEIN KINASES AND THEIR USES Jan 21, 2008 Abandoned
Array ( [id] => 4739464 [patent_doc_number] => 20080233117 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-09-25 [patent_title] => 'REDUCING TUMOR GROWTH' [patent_app_type] => utility [patent_app_number] => 12/016062 [patent_app_country] => US [patent_app_date] => 2008-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 7616 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0233/20080233117.pdf [firstpage_image] =>[orig_patent_app_number] => 12016062 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/016062
REDUCING TUMOR GROWTH Jan 16, 2008 Abandoned
Array ( [id] => 5545371 [patent_doc_number] => 20090155248 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-06-18 [patent_title] => 'Antibodies to MT-SP1 serine protease' [patent_app_type] => utility [patent_app_number] => 12/014067 [patent_app_country] => US [patent_app_date] => 2008-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 36417 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20090155248.pdf [firstpage_image] =>[orig_patent_app_number] => 12014067 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/014067
Antibodies to MT-SP1 serine protease Jan 13, 2008 Abandoned
Array ( [id] => 4681807 [patent_doc_number] => 20080248033 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-09 [patent_title] => 'VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors' [patent_app_type] => utility [patent_app_number] => 12/002605 [patent_app_country] => US [patent_app_date] => 2007-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 46398 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20080248033.pdf [firstpage_image] =>[orig_patent_app_number] => 12002605 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/002605
VEGF-specific antagonists for adjuvant and neoadjuvant therapy and the treatment of early stage tumors Dec 17, 2007 Abandoned
Array ( [id] => 6580520 [patent_doc_number] => 20100129791 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-05-27 [patent_title] => 'cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product' [patent_app_type] => utility [patent_app_number] => 11/956680 [patent_app_country] => US [patent_app_date] => 2007-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 22689 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0129/20100129791.pdf [firstpage_image] =>[orig_patent_app_number] => 11956680 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/956680
cDNA Encoding a Gene Bog (B5T Over-Expressed Gene) and its Protein Product Dec 13, 2007 Abandoned
Array ( [id] => 4751951 [patent_doc_number] => 20080160024 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-07-03 [patent_title] => 'INHIBITION OF CANCER METASTASIS' [patent_app_type] => utility [patent_app_number] => 11/952198 [patent_app_country] => US [patent_app_date] => 2007-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 8023 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0160/20080160024.pdf [firstpage_image] =>[orig_patent_app_number] => 11952198 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/952198
INHIBITION OF CANCER METASTASIS Dec 6, 2007 Abandoned
Menu